Stage I-III non-small cell lung cancer (NSCLC).
Conditions
Interventions
Stage I-III non-small cell lung cancer (NSCLC).:none
Sponsors
Beijing Chao-Yang Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with lung cancer who visit Chaoyang Hospital; 2.Aged between 18 to 80 years old; 3.Willing to participate in the study and have signed the informed consent form; 4.Confirmed non-small cell lung cancer (NSCLC) patients who have undergone radiofrequency ablation treatment; 5.Clinical TNM staging is I-III (AJCC 8th Edition); 6.Have undergone CT examination in our hospital before treatment; 7.Blood samples have been collected and preserved before treatment
Exclusion criteria
Exclusion criteria: 1.Subjects with a history of other primary malignant tumors; subjects with other in situ cancers who have no evidence of disease and do not require treatment for 5 years or more can participate in the study; 2.Subjects with severe comorbidities, such as those with severe heart disease; 3.Subjects from whom insufficient tissue specimens cannot be obtained for genetic testing; 4.History of known Human Immunodeficiency Virus (HIV) disease or positive HIV viral tests; 5.Subjects who have undergone allogeneic transplantation (including xenogeneic heart valve transplantation); 6.Patients with undetected circulating tumor DNA (ctDNA); 7.Other conditions deemed unsuitable for participation in this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main lesion ablation rate;recurrence rate of 1 year; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to Progression; | — |
Countries
China
Contacts
Public ContactHu Bin
Beijing Chao-Yang Hospital, Capital Medical University
Outcome results
None listed